# Biliverdin Reductase A in Chronic Hepatitis C Virus Infection

> **NCT01112033** · — · COMPLETED · sponsor: **Charles University, Czech Republic** · enrollment: 113 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01112033
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2013-03
- **Final completion:** 2013-06
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2015-08-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01112033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01112033, "Biliverdin Reductase A in Chronic Hepatitis C Virus Infection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01112033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*